ClostraBio, a biotechnology company developing next-generation probiotics to transform gut health, today announced several major milestones: the commercial launch of its first product in partnership ...
The US Food and Drug Administration (FDA) has released guidance about innovative trial designs for cell and gene therapy (CGT) studies. In the eight-page draft guidance, titled 'Innovative Designs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback